<--- Back to Details
First PageDocument Content
Oncolytic virus / Adenoviridae / ORCA / Prostate cancer / Cancer research / Medicine / Viruses / Experimental cancer treatments
Date: 2014-07-10 04:38:52
Oncolytic virus
Adenoviridae
ORCA
Prostate cancer
Cancer research
Medicine
Viruses
Experimental cancer treatments

Press release Grant T1 patent 4JUL2011

Add to Reading List

Source URL: orca-therapeutics.nl

Download Document from Source Website

File Size: 61,99 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Medicine / Clinical medicine / Cancer / Virotherapy / Biotechnology / Experimental cancer treatments / Antineoplastic drugs / Cancer treatments / Melanoma / Oncolytic virus / Oncolytic herpes virus / Ipilimumab

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

DocID: 1rePY - View Document

Biotechnology / Biology / Nature / Experimental cancer treatments / Versant / Oncolytic virus / Biopharmaceutical

FOR  IMMEDIATE  RELEASE        

DocID: 1pOi3 - View Document

Medicine / Clinical medicine / Medical research / Virotherapy / Drug discovery / Pharmaceutical industry / Experimental cancer treatments / Immunotherapy / Drug development / Pre-clinical development / Oncolytic virus

WORLD PRECLINICAL CONGRESS June 14-17, 2016  Westin Boston Waterfront, Boston, MA

DocID: 1nhVB - View Document

Experimental cancer treatments / Medical research / Applied genetics / Oncolytic virus / Viral vector / Gene therapy / Chimeric antigen receptor / T cell / Virotherapy / Biology / Gene delivery / Molecular biology

Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

DocID: 1gtbO - View Document